834 / 1138
SBRT for locally advanced PC
• (Very) short overall survival – similar to systemic treatment only
• Interpretation of promising LC considering OS ?
SBRT for pancreatic cancer
Study
Patients
Median OS
LC
Hoyer 2005
Phase II
22
5.4
months
57% @ 6m
Koong 2005
Phase II
17
8.3
months
16 / 17
Schellenberg 2008
Phase II
16
11.4 months
81%
Schellenberg 2011
Phase II
20
11.8 months
94% @ 1a
ESTRO SBRT Course 2014 - Emerging SBRT indications
9